New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For ADI;CTRX;DISCA;EQIX;LBTYA;LMCA;REGN;SBAC;VRSK;WDC From The Last 14 Days
Check below for free stories on ADI;CTRX;DISCA;EQIX;LBTYA;LMCA;REGN;SBAC;VRSK;WDC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | all recent news | >>
July 30, 2014
12:33 EDTREGNRegeneron, Sanofi likely to file alirocumab BLA this year, says Piper Jaffray
Subscribe for More Information
12:27 EDTREGNOn The Fly: Midday Wrap
Subscribe for More Information
08:56 EDTEQIXEquinix August weekly volatility elevated into Q2 and sales outlook
Subscribe for More Information
08:08 EDTREGNSanofi and Regeneron report positive Phase 2 results of alirocumab
Subscribe for More Information
July 29, 2014
18:38 EDTREGNRegeneron receives FDA approval for EYLEA for treatment of DME
Regeneron Pharmaceuticals announced that the FDA has approved EYLEA Injection for the treatment of Diabetic Macular Edema, or DME. The approval of EYLEA in DME was based on the one-year data from the phase 3 VISTA-DME and VIVID-DME studies of 862 patients. In Europe, the Committee for Medicinal Products for Human Use has given a positive opinion recommending approval for EYLEA in the treatment of DME. Regulatory submissions have also been made in Japan, Asia Pacific, and Latin America for the treatment of DME. In Japan, EYLEA has been additionally submitted for approval to regulators for the treatment of choroidal neovascularization secondary to pathologic myopia. A regulatory submission has been made in the U.S. and Europe for EYLEA for the treatment of Macular Edema following Branch Retinal Vein Occlusion.
16:32 EDTVRSKVerisk Analytics reports Q2 adjusted EPS 57c, consensus 56c
Subscribe for More Information
15:53 EDTVRSKNotable companies reporting after market close
Subscribe for More Information
07:55 EDTCTRXLeerink a buyer of Catamaran ahead of Q2 results
Leerink says it's a buyer of Catamaran (CTRX) ahead of the company's Q2 results as it believes shares have more room to run. The firm is cautious on Express Scripts (ESRX) after hearing from a specialist that service challenges may impact the company's 2015 and 2016 selling seasons. The firm remains positive on CVS Caremark (CVS), but notes shares have outperformed and the company could see retail pressure from recent drug inflation trends.
July 24, 2014
16:34 EDTSBACSBA Communications sees FY14 revenue $1.5B-$1.52B, consensus $1.48B
Subscribe for More Information
16:33 EDTSBACSBA Communications sees Q3 revenue $380.5M-$390.5M, consensus $379M
Subscribe for More Information
16:31 EDTSBACSBA Communications reports Q2 EPS (7c), consensus (1c)
Subscribe for More Information
10:43 EDTLBTYALiberty Global offers to sell Film1 to win Ziggo deal approval, Reuters says
Subscribe for More Information
10:03 EDTEQIXOn The Fly: Analyst Downgrade Summary
Today's noteworthy initiations include: CECO Environmental (CECE) initiated with a Buy at Canaccord... CorMedix (CRMD) initiated with a Buy at Roth Capital... CyrusOne (CONE) initiated with an Equal Weight at Barclays... Dangdang (DANG) initiated with a Buy at Citigroup... Equinix (EQIX) initiated with an Equal Weight at Barclays... FactSet (FDS) initiated with a Buy at Jefferies... JMP Group (JMP) initiated with an Outperform at Barrington... Markit (MRKT) initiated with a Hold at Jefferies... Thomson Reuters (TRI) initiated with a Hold at Jefferies... Wheeler REIT (WHLR) initiated with a Buy at Maxim... Zafgen (ZFGN) initiated with an Outperform at Leerink.
05:33 EDTEQIXEquinix initiated with an Equal Weight at Barclays
Subscribe for More Information
July 23, 2014
15:31 EDTLBTYA, LMCAMalone sees Time Warner bid unlikely from tech companies, WSJ reports
Subscribe for More Information
15:00 EDTLMCALiberty Media's Malone sees tech players unlikely to bid Time Warner, DJ says
Subscribe for More Information
July 22, 2014
11:10 EDTEQIXNetflix EU expansion modestly positive for Equinix, InterXion, says Wells Fargo
Subscribe for More Information
10:46 EDTSBACHigh option volume stocks: SBAC KS EDU PII GALT EJ AXL TSEM HLF BCOR
Subscribe for More Information
07:08 EDTADIAnalog Devices completes tender offer for Hittite Microwave shares
Analog Devices (ADI) announced it has completed its tender offer to purchase all outstanding shares of common stock of Hittite Microwave Corporation (HITT) for $78.00 per share in cash, and ADI has accepted for payment and will promptly pay the depositary for all validly tendered shares. ADI expects to complete the acquisition of Hittite Microwave later today and will issue a press release to notify stakeholders. The tender offer expired at 12:00 midnight, New York City time, at the end of July 21, 2014. As of the expiration of the tender offer, 23,291,991 shares of Hittite Microwave common stock had been validly tendered and not validly withdrawn, representing approximately 74.2% of Hittite Microwave’s outstanding shares of common stock.
July 21, 2014
10:02 EDTREGNOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Adeptus Health (ADPT) initiated with a Buy at Dougherty... Amphastar (AMPH) initiated with a Buy at Jefferies... Eclipse Resources (ECR) initiated with a Neutral at SunTrust... Fidelity National (FNF) initiated with a Buy at SunTrust... First American (FAF) initiated with a Buy at SunTrust... GoPro (GPRO) initiated with a Hold at Stifel... Imprivata (IMPR) initiated with an Outperform at Wells Fargo... Lifetime Brands (LCUT) initiated with a Buy at Sidoti... Materialise (MTLS) initiated with a Buy at BB&T... Regeneron (REGN) initiated with a Buy at Argus... STAG Industrial (STAG) initiated with a Buy at Sandler O'Neill... Signature Group (SGGH) initiated with a Buy at B. Riley... TCP International (TCPI) initiated with a Buy at Canaccord... Tessera (TSRA) initiated with a Buy at Craig-Hallum... Xunlei (XNET) initiated with a Perform at Oppenheimer.
<< 1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use